Enhancing Cell and Gene Therapy scalability in Asia using 3D manufacturing platforms with microcarrier technology

China-based CytoNiche Biotechnology, a pioneer in 3D dissolvable porous microcarriers, has opened the Center of Excellen...

July 3, 2023 | Monday | Opinion
Germany-Saudi Arabian tie up of $30 M for data-driven multiomic testing

Germany-based Centogene, the essential life science partner for data-driven answers in rare and neurodegenerative diseas...

July 3, 2023 | Monday | News
Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore

Biosyngen, an immuno-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma tre...

June 28, 2023 | Wednesday | Company results
Korea's SK bioscience inks agreement on influenza research with Doherty Institute in Australia

SK bioscience, a global innovative vaccine and biotech company based in South Korea, has signed a collaboratio...

June 28, 2023 | Wednesday | News
Australia designs smart glasses to improve diagnosis and treatment of foot wounds

Mixed-reality smart glasses with holographic features are set to revolutionise the treatment of leg and foot wounds for ...

June 27, 2023 | Tuesday | News
Singapore finds effective therapeutic for killing wide range of viruses

Peruvoside, a plant-based compound that is commonly used to treat heart failure, has been discovered to be able to preve...

June 22, 2023 | Thursday | News
Korea uncovers new cancer reversion treatment strategy

Despite decades of intensive cancer research by numerous biomedical scientists, cancer still holds its place as the numb...

June 23, 2023 | Friday | News
Australian government unveils plans of building Institute for Infectious Disease

The Australian Institute for Infectious Disease (AIID) is a visionary $650 million project supported by the Victorian St...

June 21, 2023 | Wednesday | News
First South Asian microbiome company Leucine Rich Bio forays into US

Indian biotech firm Leucine Rich Bio, South Asia’s first microbiome company, is all set to foray into US healthcar...

June 21, 2023 | Wednesday | News
China to establish scientific collaborative research platform for eye diseases

The Hong Kong Polytechnic University (PolyU) has joined hands with Tianjin Medical University (TMU), China to nurture ta...

June 19, 2023 | Monday | News
China translates blood’s hidden gem Neutrophil into new generation anti-cancer therapy

Lung cancer remains the most common cancer in Hong Kong. As a leading cancer killer worldwide, its treatment still needs...

June 14, 2023 | Wednesday | News
 Triggering a collaborative initiative to accelerate biomedical R&D in South East Asia

Researchers in Asia are increasingly evaluating the significance and scope of proteomics in biomolecular discovery effor...

June 9, 2023 | Friday | Opinion
Singapore develops technique to accelerate discovery of new immunotherapies

A team of researchers from the National University of Singapore (NUS) led by Assistant Professor Cheow Lih Feng from the...

June 8, 2023 | Thursday | News
Singapore discovers novel therapy to counter antibiotic-resistant lung infections

Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-M...

June 6, 2023 | Tuesday | News
Singapore uses AI to accelerate discovery of biomarkers for chronic myeloid leukaemia treatment

Scientists at Duke-NUS Medical School, A*STAR’s Genome Institute of Singapore (GIS), Singapore General Hospital (S...

June 2, 2023 | Friday | News
Hong Kong to establish state-of-the-art facility for advanced cell therapies

The Hong Kong Science and Technology Parks Corporation (HKSTP, a public corporation set up by the Hong Kong Government) ...

May 29, 2023 | Monday | News
Australian startup Cyteph secures $1.5 M for brain cancer immunotherapy trial

Cyteph, a spin-out biotechnology company from QIMR Berghofer Medical Research Institute in Australia, has been awa...

May 30, 2023 | Tuesday | News
Korea-US partnership to co-develop therapy for Parkinson's Disease

South Korean firms HanAll Biopharma and Daewoong Pharmaceutical have entered into a co-development agreement with N...

May 26, 2023 | Friday | News